News Square
Global Crypto News · Real-time Aggregation
📚 Deep Analysis
More →GRVT Burns 1.1 Million Tokens as Countdown to Grvt 2.0 Begins
<strong>[PRESS RELEASE – Singapore, Singapore, October 20th, 2026]</strong> <strong>The discretionary buyback represents close to 1% of circulating supply and precedes four planned product milestones culminating in Grvt 2.0.</strong> <a href="https://grvt.io/" rel="nofollow noopener" target="_blank">>Grvt</a>, a self-custodial trading platform built on its own zero-knowledge (ZK) chain, announced that the Foundation’s token issuer has completed its first GRVT token buyback, purchasing and burning 1.1 million GRVT tokens on the open market. The transaction permanently removed close to 1% of GRVT’s circulating supply at the time of purchase. It marks the first of five milestones ahead of the planned launch of Grvt 2.0 at the end of November 2026. <strong>A Discretionary Buyback with On-Chain Verification</strong> The Foundation’s token issuer intends to conduct further buybacks on a monthly basis. Each transaction remains entirely at the issuer’s discretion, with no predetermined purchase amount or guaranteed schedule. Buybacks are executed through an independent execution partner, with purchased tokens transferred to a designated burn address and permanently removed from circulation. The transactions can be independently verified through the <a href="https://grvt.io/exchange/buybacks" rel="nofollow noopener" target="_blank">>public buyback dashboard</a>, which records the number of tokens purchased and burned, the percentage of circulating supply represented, cumulative burns and on-chain transaction hashes. “The GRVT token is an important part of the ecosystem we are building,” said <strong>Hong, co-founder and CEO of Grvt</strong>. “We welcome the issuer’s buybacks as a demonstration of its long-term commitment to the ecosystem and community. Grvt is expanding its products and markets, and the issuer’s buybacks sit alongside that as a supportive mechanism aimed at reducing circulating token supply.” <strong>Grvt Outlines Four Product Milestones</strong> The announcement follows GRVT’s token generation event in July 2026 and precedes a series of planned launches. <strong>Grvt Earn, scheduled for the End of October,</strong> will introduce yield opportunities backed by tokenized assets, with target yields of up to 11%. Potential returns are expected to derive from underlying asset cash flows, including interest, premiums and invoice-related income. Asset-supplying partners will be announced at launch. Target yields are not guaranteed. <strong>Stable Funding Perps, scheduled for November,</strong> will introduce perpetual futures linked to commodities, stocks, foreign exchange and indices. The contracts are planned to carry zero trading fees and use once-daily funding. Grvt aims to list more than 1,000 markets by the end of December 2026. <strong>Yield as Margin, also scheduled for November,</strong> will allow eligible Grvt Earn balances to support trading positions while continuing to accrue yield, subject to applicable product terms
OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work
OpenAI has bought Orchestra Bio, a San Francisco startup whose AI agents help drug companies keep sprawling development programs on schedule, the ChatGPT maker <a href="https://openai.com/index/openai-to-acquire-orchestra-bio/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>announced Tuesday</a>. “Our goal is to help scientists make discoveries and manage the work needed to turn them into treatments that reach patients sooner,” OpenAI said in the announcement. Orchestra’s team and platform will be folded into <a href="https://openai.com/rosalind/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>Rosalind</a>, OpenAI’s family of AI models and tools for biologists and chemists. The financial terms were not disclosed. Getting a new medicine from first idea to U.S. approval takes time—up to 15 years according to OpenAI. Every month shaved off that timeline is a month earlier that a new treatment can reach the people waiting for it, and a month earlier that the company can generate cash. The process is also absurdly expensive: bringing one approved drug to market can cost more than <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12668846/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>$2.6 billion</a>, and <a href="https://arxiv.org/pdf/2106.05386" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">fewer than 10%</a> of candidates that enter human testing ever make it to pharmacy shelves. Beyond the science itself, OpenAI says drug teams have to coordinate work across internal departments and outside partners, often relying on systems that don’t talk to each other. Those partners usually include contract research organizations, the outside labs hired to run studies, and contract manufacturers that produce the experimental drug. Orchestra’s AI agents—software that can watch over tasks and flag problems on its own—work out which activities and deadlines take the hit, gather the relevant information and compare ways to respond, while scientists and program leaders make the final call. Founded in the fall of 2022, Orchestra raised its <a href="https://jobs.8vc.com/companies/orchestra/jobs/28818089-senior-software-engineer" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>seed round</a> from Andreessen Horowitz, Definition Capital, Insight Partners, and 8VC, and about $20 million in total, according to <a href="https://www.caplight.com/company/orchestra-bio" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">Caplight data</a>. The company should not be confused with Orchestra BioMed, an unrelated Nasdaq-listed medical device maker that trades under the ticker OBIO. In April, OpenAI launched <a href="https://decrypt.co/364783/openai-gpt-rosalind-drug-discovery-life-sciences-model" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">GPT-Rosalind</a>, a model built specifically for biology and dru
Rising fuel prices are the main reason UK inflation came in higher than expected.
According to BBC, the UK's inflation rate in September was 3.5%, slightly higher than analysts' expectations. Rising fuel prices were the main reason inflation came in above expectations, and the recent sharp rise in the cost of living has largely been driven by higher fuel prices. Currently, the average price of unleaded petrol in the UK is around £1.74 per litre, while diesel is even higher at £1.99, although both have edged down slightly from the record high of £2 set earlier this month. Since most goods are transported by truck or van, the impact of fuel prices is far-reaching.
Former Alibaba P10 algorithm director is preparing an RSI startup: first-round valuation of about $80 million.
BiJie Network news: Zhu Xiaoyong, former Alibaba P10 algorithm director, is preparing to start a company focused on RSI, with a first-round valuation of about $80 million. He previously served as a principal applied scientist at Microsoft and was responsible for model R&D and self-evolution-related work at Alibaba. RSI stands for recursive self-improvement, with the goal of enabling AI to participate in improving its own training and operating methods. Zhu Xiaoyong's team plans to enter the market through open-source tools, data, and model training services, helping companies in industries such as healthcare, robotics, and chips use their own data to continuously optimize proprietary models.
UK inflation in September came in higher than expected, reinforcing the prospect of an interest rate hike.
Data from Bihang.com: According to data released by the UK Office for National Statistics on Wednesday, the inflation rate rose to 3.5% in September, up from 3.1% in August and exceeding the 3.4% previously forecast by economists surveyed by Reuters. This figure not only puts pressure on household finances but also further strengthens the case for the Bank of England to raise interest rates next month. The market expects the Bank of England to raise interest rates by 25 basis points next month, bringing the rate up to 4%. This is the first such action by the Bank of England since the Iran war triggered a global surge in energy prices. The Monetary Policy Committee had predicted that inflation would reach 4% in the first quarter of next year, driven by another rise in energy prices—twice its 2% target level.
Gate's latest proof-of-reserves report: total reserve scale rises to $8.688 billion.
CoinWorld data: Gate has released its latest reserve report. As of October 18, 2026, the platform's total reserves rose to $8.688 billion, up 5.7% quarter-over-quarter, with an overall reserve ratio of 118.49%, continuing to exceed the 100% industry safety benchmark. This report covers 500 cryptocurrencies. In terms of core asset reserves, BTC user assets grew to 21,156 BTC, platform reserves grew to 25,727 BTC, and the reserve ratio rose from 120.32% to 121.60%. ETH user assets grew to 362,785 ETH, platform reserves grew to 449,042 ETH, and the reserve ratio rose from 123.59% to 123.78%. In terms of stablecoins, the total user assets of USDT, USD1, GUSD, and USDC amounted to approximately $1.497 billion, with corresponding platform reserves of $1.746 billion, resulting in a combined reserve ratio of 116.59%. In addition, the reserve ratios of major assets such as DOGE, GT, and SOL reached 106.76%, 129.00%, and 102.51%, respectively, all above the 100% safety line.
Arthur Hayes: The Flop Labs testnet and airdrop have not yet launched, and there is currently no FLOP token.
CoinWorld news: Arthur Hayes stated on X platform that the Flop Labs testnet and airdrop will launch in a few weeks. There is currently no FLOP token, and any claims of the existence of a FLOP token are scams.
MEXC announces its exit from the Russian and Belarusian markets.
According to CoinWorld news, the MEXC exchange has announced that it will stop serving users in Russia and Belarus. Affected customers will receive individual notifications instructing them to close positions and withdraw funds. The decision was announced on October 20, and MEXC stated that the move is part of its global compliance efforts. Users who do not receive a notification can continue trading under the existing terms of service. MEXC emphasized that customer assets will be protected during this process, but did not specify the exact number of affected accounts or when the service termination will be completed. The exchange also warned users to beware of phishing links and impersonation attempts, stressing that its representatives will not request passwords, seed phrases, or asset transfers through private messages.
UK CPI rose 0.4% month-on-month.
CoinWorld data: The UK's latest Consumer Price Index (CPI) rose 0.4% month-on-month, above the market expectation of 0.3% but below last month's 0.5%.
UK September core CPI year-on-year came in at 2.8%, versus expectations of 2.7%.
CoinWorld data: The UK's core CPI annual rate for September was 2.8%, higher than the expected 2.7% and the previous value of 2.60%.